KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib

KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib

Contributor(s):
Varmus, Harold
PLoS Medicine
Miller, Vincent
Kris, Mark
Heelan, Robert
Pao, William
Riely, Gregory J.
Wang, Theresa Y.
Zakowski, Maureen
Ladanyi, Marc
Pan, Qiulu
Publication:
Public Library of Science, January 2005
Language(s):
English
Format:
Text
Subject(s):
Mutation
Lung Neoplasms
Genre(s):
Archival Materials
Articles
Abstract:
This was Varmus's first research article in PLoS, the open-access online publishing venture that he helped to establish in 2000.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
5 pages
NLM Unique ID:
101584926X492 (See in Profiles in Science)
Profiles in Science ID:
MVBCFB
Permanent Link:
http://resource.nlm.nih.gov/101584926X492
Archival Collection:
The Harold Varmus Papers (Profiles in Science)